Risk of Death in Colorectal Cancer Patients with Multi-morbidities of Metabolic Syndrome: A Retrospective Multicohort Analysis
Qingting Feng, Lingkai Xu, Lin Li, Junlan Qiu, Ziwei Huang, Yiqing Jiang, Tao Wen, Shun Lu, Fang Meng, Xiaochen Shu
Cancer Res Treat. 2021;53(3):714-723. Published online 2020 Dec 2 DOI: https://doi.org/10.4143/crt.2020.481
Citations to this article as recorded by 
The metabolic syndrome and its components as prognostic factors in colorectal cancer: A meta‐analysis and systematic review
Bo Lu, Jia‐Ming Qian, Jing‐Nan Li
Journal of Gastroenterology and Hepatology.2023; 38(2): 187. CrossRef
Dysbiotic microbiome variation in colorectal cancer patients is linked to lifestyles and metabolic diseases
Tung Hoang, Minjung Kim, Ji Won Park, Seung-Yong Jeong, Jeeyoo Lee, Aesun Shin
BMC Microbiology.2023;[Epub] CrossRef
Comparing Long-Term Survival Outcomes for Muscle-Invasive Bladder Cancer Patients Who Underwent with Radical Cystectomy and Bladder-Sparing Trimodality Therapy: A Multicentre Cohort Analysis
Junlan Qiu, Haifeng Zhang, Dongkui Xu, Lin Li, Lingkai Xu, Yiqing Jiang, Tao Wen, Shun Lu, Fang Meng, Lin Feng, Xiaochen Shu, Pierfrancesco Franco
Journal of Oncology.2022; 2022: 1. CrossRef
Cosmc transfection decreases malignant behavior of Tn+ cells and enhances sensitivity to apoptosis when induced by Apo2L/TRAIL via alteration of O-glycan structure
Ruisong Ding, Xingyou Hu, Wen Hu, Zhenzhen Du, Panpan Huang, Mengyang Wang, Jiaoyue Sheng, Yanchao Ma, Ailing Wang, Xiying Luan, Menghua Dong, Qizhi Cao, Yanfen Zou, Tao Hu
Aging.2021; 13(19): 23393. CrossRef